Bajaj Broking Research has issued stock market recommendations for the upcoming week, advising investors to consider Piramal Pharma and PTC India. The Nifty is anticipated to experience volatility, with crucial support levels identified at 22,000-21,700. Investors are urged to keep a close eye on these stocks as they navigate the fluctuations in the market. This advice comes amidst the backdrop of an uncertain economic climate, where strategic investment decisions are paramount for success. As the market continues to react to various external factors, such as global trends and domestic policies, staying informed and following expert recommendations can be key to maximizing returns. For those looking to make informed choices in the stock market, the insights provided by Bajaj Broking Research offer valuable guidance for the week ahead. By considering the potential of Piramal Pharma and PTC India, investors can position themselves for success in the face of market fluctuations. As always, it is essential to conduct thorough research and seek professional advice before making any investment decisions.